Androgens
19-Norandrostenedione
A nandrolone-related precursor whose small combined-supplement trial did not show a strength or body-composition benefit.
Very small randomized human combination trial; evidence checked 2026-10-01
Also known as: 19-nor-4-androstenedione

Practical use
Evidence interpretation and concrete review questions
- Inspect all ingredients
- Distinguish a single compound from a precursor blend.
- Check sample size
- Treat strong marketing claims cautiously when the human comparison involved only ten people.
- Keep uncertainty balanced
- Do not convert limited efficacy evidence into reassurance about health effects.
Overview
This entry concerns 19-nor-4-androstene-3,17-dione. The “19-nor” designation describes a structural difference; it does not make the compound identical to nandrolone or to 19-norandrostenediol.
Risks and limitations
The small trial was not a meaningful test of uncommon or long-term harms. Lack of a demonstrated training benefit and lack of reported serious events cannot be combined into a safety claim.
How to read this
Precursor marketing assumes conversion produces a useful net effect. That assumption must be tested in people, including outcomes and adverse effects.
Research explained
Combined norsteroids in trained men
Who was studied
Ten resistance-trained men randomized double-blind to a combination of norandrostenedione and norandrostenediol or placebo for eight weeks; five per group.
What was found
No significant pre-to-post changes in strength or body-composition measures were found in either group.
What it cannot establish
Extremely small sample and two active ingredients. The trial cannot isolate this molecule or rule out smaller effects and uncommon harms.
Read the original studyTwo ingredients prevent a single-ingredient conclusion
The study cannot tell us what either precursor would do alone.
Supporting sourceNames must retain their functional groups
A dione and a diol are distinct chemical structures even when their steroid backbone is similar.
Supporting sourceClaims versus findings
Not established
Nandrolone-related chemistry guarantees a training benefit.
The cited combined-product trial did not demonstrate one.
Check the evidenceCommon questions
Does a nonsignificant result prove absolutely no effect?
No. Five participants per group give limited precision, but they also do not support a confident benefit claim.
SourceSources
Combined norsteroids in trained men
PubChem chemical identity; checked October 1, 2026
Sources checked 2026-10-01.
General education; not a personal treatment plan.
